Westpac Banking Corp Merck & Co., Inc. Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Westpac Banking Corp holds 102,744 shares of MRK stock, worth $10.3 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

102,744

Previous 90,100 14.03%

Holding current value

$10.3 Million

Previous $11.2 Billion 4.6%

% of portfolio

0.78%

Previous 0.88%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$111.15 - $128.97 $1.41 Million - $1.63 Million	12,644 Added 14.03%	102,744 $11.7 Billion
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $11.1 Million - $11.9 Million	89,852 Added 36230.65%	90,100 $11.2 Billion
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $11 Million - $11.9 Million	-89,215 Reduced 99.72%	248 $11.2 Billion
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $1.68 Million - $1.95 Million	-14,795 Reduced 14.19%	89,463 $11.8 Billion
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $1.93 Million - $2.1 Million	-19,270 Reduced 15.6%	104,258 $11.4 Billion
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $1.3 Million - $1.44 Million	12,628 Added 11.39%	123,528 $12.7 Billion
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $35.2 Million - $38.3 Million	-323,725 Reduced 74.48%	110,900 $12.8 Billion
Q1 2023 May 03, 2023	SELL	$102.94 - $114.86 $4.94 Million - $5.51 Million	-47,983 Reduced 9.94%	434,625 $46.2 Billion
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $6.73 Million - $8.62 Million	76,911 Added 18.96%	482,608 $53.5 Billion
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $1.51 Million - $1.7 Million	17,888 Added 4.61%	405,697 $34.9 Billion
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $3.09 Million - $3.5 Million	36,953 Added 10.53%	387,809 $35.4 Billion
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $1.19 Million - $1.34 Million	-16,248 Reduced 4.43%	350,856 $28.8 Million
Q4 2021 Feb 08, 2022	SELL	$72.28 - $90.54 $985,320 - $1.23 Million	-13,632 Reduced 3.58%	367,104 $28.1 Billion
Q3 2021 Oct 27, 2021	SELL	$71.68 - $78.83 $547,850 - $602,497	-7,643 Reduced 1.97%	380,736 $28.6 Million
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $904,397 - $1 Million	-12,863 Reduced 3.21%	388,379 $30.2 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $709,258 - $835,433	10,300 Added 2.63%	401,242 $29.5 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $875,952 - $972,128	12,205 Added 3.22%	390,942 $30.5 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $401,172 - $454,731	5,482 Added 1.47%	378,737 $30 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $1.52 Million - $1.73 Million	-21,611 Reduced 5.47%	373,255 $27.5 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $503,268 - $697,554	7,943 Added 2.05%	394,866 $29 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $2.55 Million - $2.88 Million	32,849 Added 9.28%	386,923 $33.6 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $1.57 Million - $1.71 Million	-20,608 Reduced 5.5%	354,074 $28.4 Million
Q2 2019 Aug 01, 2019	BUY	$69.84 - $81.59 $1.32 Million - $1.54 Million	18,837 Added 5.29%	374,682 $0
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $78,138 - $89,121	-1,123 Reduced 0.31%	355,845 $0
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $970,901 - $1.13 Million	14,882 Added 4.35%	356,968 $26 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $69,228 - $81,408	-1,200 Reduced 0.35%	342,086 $0
Q2 2018 Jul 18, 2018	SELL	$50.83 - $59.72 $92,968 - $109,227	-1,829 Reduced 0.53%	343,286 $0
Q1 2018 May 01, 2018	BUY	$50.96 - $59.23 $4.22 Million - $4.9 Million	82,747 Added 31.54%	345,115 $0
Q4 2017 Jan 18, 2018	BUY	$51.62 - $61.64 $374,503 - $447,198	7,255 Added 2.84%	262,368 $0
Q3 2017 Oct 30, 2017	BUY	$58.67 - $63.13 $15 Million - $16.1 Million	255,113	255,113 $0

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Merck & Co., Inc. Transaction History